Business Finland granted Sartar R&D Funding

We are proud to inform that the national innovation funding body Business Finland has granted R&D funding for Sartar Therapeutics. This R&D loan will allow us to advance the development of our product SAR001 towards clinical trials. We consider this positive decision as a significant credit for our technology for the treatment of soft tissue sarcomas.